| Pharmacoproteomic analysis reveals that metapristone (RU486 metabolite) intervenes E-cadherin and vimentin to realize cancer metastasis chemoprevention | |
| Yu, Suhong; Yan, Cuicui; Yang, Xingtian; He, Sudang; Liu, Jian; Qin, Chongtao; Huang, Chuanzhong; Lu, Yusheng; Tian, Zhongping; Jia, Lee | |
| 刊名 | SCIENTIFIC REPORTS
 |
| 2016 | |
| 卷号 | 6 |
| ISSN号 | 2045-2322 |
| URL标识 | 查看原文 |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/2895354 |
| 专题 | 福州大学 |
| 推荐引用方式 GB/T 7714 | Yu, Suhong,Yan, Cuicui,Yang, Xingtian,et al. Pharmacoproteomic analysis reveals that metapristone (RU486 metabolite) intervenes E-cadherin and vimentin to realize cancer metastasis chemoprevention[J]. SCIENTIFIC REPORTS,2016,6. |
| APA | Yu, Suhong.,Yan, Cuicui.,Yang, Xingtian.,He, Sudang.,Liu, Jian.,...&Jia, Lee.(2016).Pharmacoproteomic analysis reveals that metapristone (RU486 metabolite) intervenes E-cadherin and vimentin to realize cancer metastasis chemoprevention.SCIENTIFIC REPORTS,6. |
| MLA | Yu, Suhong,et al."Pharmacoproteomic analysis reveals that metapristone (RU486 metabolite) intervenes E-cadherin and vimentin to realize cancer metastasis chemoprevention".SCIENTIFIC REPORTS 6(2016). |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论